ICON and ICHOM are creating the world's first global healthcare outcomes benchmarking program DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and ...
To develop a core outcome set for Achilles tendinopathy (COS-AT) for use in clinical trials we performed a five-step process including (1) a systematic review of available outcome measurement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results